David Beenhouwer, Robert Wallis, Michael Broder, Daniel E Furst. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh: See more » AnimalsAntibodies, Monoclonal/immunologyAntibodies, Monoclonal/therapeutic useAntirheumatic Agents/immunologyAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapyArthritis, Rheumatoid/immunologyGranulomatous Disease, Chronic/drug therapyGranulomatous Disease, Chronic/immunologyHumansInfliximabReceptors, Tumor Necrosis Factor/immunologyReceptors, Tumor Necrosis Factor/therapeutic useTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Antibodies, MonoclonalAntirheumatic AgentsReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaInfliximab
Year: 2004 PMID: 15487038
Source DB: PubMed Journal: J Rheumatol ISSN: 0315-162X Impact factor: 4.666